{"altmetric_id":23370284,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":12},"twitter":{"unique_users_count":12,"unique_users":["NatRevClinOncol","1978rikut","paezini","CancerWallonia","BiotechRadar","DrMoJoHeM","strong_bio","fabianaperna","Mfitzg79Mark","YoungChris27040","KathrynSkelding","SaudiLeukemia"],"posts_count":12}},"selected_quotes":["#CART cell #Ibrutinib #Immunotherapy #ImmunoOnc","HAEMATOLOGICAL CANCER: After ibrutinib, CAR T cells induce responses - #leusm #hemeonc #ImmunoOnc"],"citation":{"altmetric_jid":"4f6fa62f3cf058f61000825e","authors":["Diana Romero"],"doi":"10.1038\/nrclinonc.2017.124","first_seen_on":"2017-08-02T14:32:15+00:00","funders":["niehs"],"handles":[],"issns":["1759-4774","1759-4782"],"journal":"Nature Reviews Clinical Oncology","last_mentioned_on":1501784091,"links":["http:\/\/www.nature.com\/nrclinonc\/journal\/vaop\/ncurrent\/full\/nrclinonc.2017.124.html?WT.mc_id=TWT_NatRevClinOncol&foxtrotcallback=true"],"pmid":"28762387","pubdate":"2017-08-01T00:00:00+00:00","publisher":"Nature Research","scopus_subjects":["Medicine","Health Sciences"],"subjects":["neoplasms"],"title":"Haematological cancer: After ibrutinib, CAR T cells induce responses","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/haematological-cancer-after-ibrutinib-car-t-cells-induce-responses"},"altmetric_score":{"score":5.45,"score_history":{"1y":5.45,"6m":5.45,"3m":5.45,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.45},"context_for_score":{"all":{"total_number_of_other_articles":8317445,"mean":7.0084957256017,"rank":1523618,"this_scored_higher_than_pct":81,"this_scored_higher_than":6789019,"rank_type":"exact","sample_size":8317445,"percentile":81},"similar_age_3m":{"total_number_of_other_articles":176398,"mean":11.814677948038,"rank":40615,"this_scored_higher_than_pct":76,"this_scored_higher_than":135575,"rank_type":"exact","sample_size":176398,"percentile":76},"this_journal":{"total_number_of_other_articles":1205,"mean":9.5850581395349,"rank":522,"this_scored_higher_than_pct":56,"this_scored_higher_than":682,"rank_type":"exact","sample_size":1205,"percentile":56},"similar_age_this_journal_3m":{"total_number_of_other_articles":54,"mean":17.08679245283,"rank":40,"this_scored_higher_than_pct":25,"this_scored_higher_than":14,"rank_type":"exact","sample_size":54,"percentile":25}}},"demographics":{"poster_types":{"member_of_the_public":8,"researcher":3,"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1,"Members of the public":8,"Scientists":3}},"mendeley":{"by_status":{"Student  > Master":1},"by_discipline":{"Agricultural and Biological Sciences":1}}},"geo":{"twitter":{"GB":1,"JP":1,"FR":1,"ES":1,"US":1,"AU":2,"SA":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/NatRevClinOncol\/statuses\/892754867055247360","license":"gnip","citation_ids":[23370284],"posted_on":"2017-08-02T14:32:01+00:00","author":{"name":"NatureRevClinOncol","url":"http:\/\/www.nature.com\/nrclinonc\/index.html","image":"https:\/\/pbs.twimg.com\/profile_images\/1587954262\/nrclinonc_Twitter_logo_normal.jpg","description":"The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.","id_on_source":"NatRevClinOncol","tweeter_id":"347276297","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":10335},"tweet_id":"892754867055247360"},{"url":"http:\/\/twitter.com\/1978rikut\/statuses\/892755145477337088","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[23370284],"posted_on":"2017-08-02T14:33:07+00:00","author":{"name":"\u30ab\u30df\u30fc\u30e6\u30fb\u30d2\u30a4\u30ed_\u03c6(\uff65_\uff65","image":"https:\/\/pbs.twimg.com\/profile_images\/867373562809782272\/1qbtdiM__normal.jpg","description":"\u77b3\u3092\u305d\u3089\u3055\u305a\u306b \u71b1\u304f\u6fc0\u3057\u304f\u751f\u304d\u3066\u3044\u305f\u3044","id_on_source":"1978rikut","tweeter_id":"152266318","geo":{"lt":35.72526,"ln":139.5383,"country":"JP"},"followers":128},"tweet_id":"892755145477337088"},{"url":"http:\/\/twitter.com\/paezini\/statuses\/892757057035788289","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[23370284],"posted_on":"2017-08-02T14:40:43+00:00","author":{"name":"A.P\u00e1ez.E","image":"https:\/\/pbs.twimg.com\/profile_images\/816680672433618944\/q72ICz0G_normal.jpg","description":"Fellow of the International Council of Ophthalmology (FICO).","id_on_source":"paezini","tweeter_id":"366696552","geo":{"lt":null,"ln":null},"followers":253},"tweet_id":"892757057035788289"},{"url":"http:\/\/twitter.com\/CancerWallonia\/statuses\/892757678749097984","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[23370284],"posted_on":"2017-08-02T14:43:11+00:00","author":{"name":"CancerWallonia","image":"https:\/\/pbs.twimg.com\/profile_images\/623178120615604224\/unGEOij0_normal.jpg","description":"Cancer: from Wallonia to the World, from the World to Wallonia -  Cancer: la Wallonie parle au Monde, le Monde parle \u00e0 la Wallonie","id_on_source":"CancerWallonia","tweeter_id":"2848852120","geo":{"lt":null,"ln":null},"followers":603},"tweet_id":"892757678749097984"},{"url":"http:\/\/twitter.com\/BiotechRadar\/statuses\/892758282049380352","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[23370284],"posted_on":"2017-08-02T14:45:35+00:00","author":{"name":"Biotech Radar","image":"https:\/\/pbs.twimg.com\/profile_images\/693444152265146369\/T6cOJomc_normal.png","description":"Anticipate the catalysts of EU biotechs (focus on FR\/BE\/NL\/DE listed in Paris\/Bru.\/Ams.).Views=owner's only.RT\/like =\/= endorsement","id_on_source":"BiotechRadar","tweeter_id":"3142088601","geo":{"lt":46,"ln":2,"country":"FR"},"followers":2498},"tweet_id":"892758282049380352"},{"url":"http:\/\/twitter.com\/DrMoJoHeM\/statuses\/892758466707804161","license":"gnip","citation_ids":[23370284],"posted_on":"2017-08-02T14:46:19+00:00","author":{"name":"MoJo","image":"https:\/\/pbs.twimg.com\/profile_images\/498137782372818944\/M-WyvOgc_normal.jpeg","description":"Hematology\/Infectious Diseases","id_on_source":"DrMoJoHeM","tweeter_id":"2717639346","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":224},"tweet_id":"892758466707804161"},{"url":"http:\/\/twitter.com\/strong_bio\/statuses\/892761120846430208","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[23370284],"posted_on":"2017-08-02T14:56:52+00:00","author":{"name":"Strong_bio","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"strong_bio","tweeter_id":"834201804409692160","geo":{"lt":null,"ln":null},"followers":20},"tweet_id":"892761120846430208"},{"url":"http:\/\/twitter.com\/fabianaperna\/statuses\/892782699370479616","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[23370284],"posted_on":"2017-08-02T16:22:37+00:00","author":{"name":"Fabiana Perna MD PhD","image":"https:\/\/pbs.twimg.com\/profile_images\/829528509357891592\/jxG1W-Oq_normal.jpg","description":"I am a physician-scientist developing new therapies for patients with leukemia @sloan_kettering. Hematologist, ECFMG certified.","id_on_source":"fabianaperna","tweeter_id":"559777282","geo":{"lt":40.78343,"ln":-73.96625,"country":"US"},"followers":223},"tweet_id":"892782699370479616"},{"url":"http:\/\/twitter.com\/Mfitzg79Mark\/statuses\/892821259427471361","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[23370284],"posted_on":"2017-08-02T18:55:50+00:00","author":{"name":"Mark Fitzgerald","image":"https:\/\/pbs.twimg.com\/profile_images\/587289678547648512\/9kkppz35_normal.jpg","description":"organic chemist with a weird accent from NJ.","id_on_source":"Mfitzg79Mark","tweeter_id":"3001224033","geo":{"lt":null,"ln":null},"followers":73},"tweet_id":"892821259427471361"},{"url":"http:\/\/twitter.com\/YoungChris27040\/statuses\/892884080940826624","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[23370284],"posted_on":"2017-08-02T23:05:28+00:00","author":{"name":"Chris Young","image":"https:\/\/pbs.twimg.com\/profile_images\/832595198987296769\/VjFKip8q_normal.jpg","description":"Advocate #equality #disabilities #health LT #investor \ud83d\udd0eP-value mrkt intel\" #Biotech paradigm-shift research, pre-eminently humane. retweets not endorsements.","id_on_source":"YoungChris27040","tweeter_id":"1415149603","geo":{"lt":-37.83333,"ln":144.96667,"country":"AU"},"followers":1343},"tweet_id":"892884080940826624"},{"url":"http:\/\/twitter.com\/KathrynSkelding\/statuses\/893008426590011392","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[23370284],"posted_on":"2017-08-03T07:19:34+00:00","author":{"name":"Kathryn Skelding","url":"http:\/\/www.newcastle.edu.au\/profile\/kathryn-skelding","image":"https:\/\/pbs.twimg.com\/profile_images\/608063691410579456\/0rMPfjqR_normal.jpg","description":"Cancer Researcher and Senior Lecturer at UON & HMRI. Avid reader, wannabe chef, & happy traveller.","id_on_source":"KathrynSkelding","tweeter_id":"3314178641","geo":{"lt":-32.92715,"ln":151.77647,"country":"AU"},"followers":663},"tweet_id":"893008426590011392"},{"url":"http:\/\/twitter.com\/SaudiLeukemia\/statuses\/893173332606156800","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[23370284],"posted_on":"2017-08-03T18:14:51+00:00","author":{"name":"Saudi Leukemia Net","url":"http:\/\/www.saudileukemia.org","image":"https:\/\/pbs.twimg.com\/profile_images\/678811169671507969\/h6ewOJc0_normal.jpg","description":"\u0627\u0644\u0634\u0628\u0643\u0629 \u0627\u0644\u0633\u0639\u0648\u062f\u064a\u0629 \u0644\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062f\u0645","id_on_source":"SaudiLeukemia","tweeter_id":"4462240413","geo":{"lt":24.68773,"ln":46.72185,"country":"SA"},"followers":670},"tweet_id":"893173332606156800"}]}}